新穎生醫 6810.TW Value Analysis
TW StockBiotech. & Medical
(No presentation for 6810)
6810 Value Score
3
24
15
Limited Growth
- AI analysis rates 6810 with a lower value score of 2.
- It is mainly due to unstable operating cash flow, along with lower ROE.
- Over the past 3 months, 6810 has maintained a consecutive value rating of 2.0, higher than the rating of 0.3 over the past 3 years, indicating increasing opportunities for enterprise value growth.
- Compared to all stocks in the Biotech. & Medical sector, 6810 has a medium value rating.
6810 Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2024/07/16 (Weekly Update)
6810 Financial Forecast
Unit : TWD
Update to 2025/5/9 (Quarterly Update)
6810 Earnings Table
No related data records
6810 Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
6810 Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of 6810 from 2021/08 till Now
- -
- Cumulative Return
- -
- Annual Return
- -
- Volatility
- -
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from August, 2021 to May, 2025. (Total Trades: 0)
| 6810 | Sector | TW Overall Market | |
|---|---|---|---|
| Wining Rate | - | 46% | 53% |
| Avg Return | - | 21.1% | 45.4% |
| Avg Profit | - | 72.2% | 102.9% |
| Avg Loss | - | -22.4% | -20.3% |
| Avg Risk-Reward Ratio | - | 322.8% | 505.8% |
Update to 2025/5/10 (Daily Update)